Quest Diagnostics (DGX) Total Non-Current Liabilities (2016 - 2025)
Quest Diagnostics (DGX) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $8.1 billion as the latest value for Q4 2025.
- Quarterly Total Non-Current Liabilities fell 3.62% to $8.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 billion through Dec 2025, down 3.62% year-over-year, with the annual reading at $8.1 billion for FY2025, 3.62% down from the prior year.
- Total Non-Current Liabilities hit $8.1 billion in Q4 2025 for Quest Diagnostics, up from $7.9 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $8.4 billion in Q4 2024 to a low of $5.9 billion in Q1 2023.
- Historically, Total Non-Current Liabilities has averaged $6.9 billion across 5 years, with a median of $6.5 billion in 2021.
- Biggest five-year swings in Total Non-Current Liabilities: dropped 8.33% in 2021 and later skyrocketed 36.09% in 2024.
- Year by year, Total Non-Current Liabilities stood at $6.3 billion in 2021, then fell by 3.8% to $6.1 billion in 2022, then increased by 11.63% to $6.8 billion in 2023, then rose by 23.49% to $8.4 billion in 2024, then fell by 3.62% to $8.1 billion in 2025.
- Business Quant data shows Total Non-Current Liabilities for DGX at $8.1 billion in Q4 2025, $7.9 billion in Q3 2025, and $7.8 billion in Q2 2025.